New Year's Day drug price hikes hit more than 250 meds

Listen
Text
  • Small
  • Medium
  • Large

Drugmakers hiked the list prices of more than 250 drugs on New Year's Day in the U.S., according to data from healthcare research firm 3 Axis Advisors.

Reuters exclusively reported Jan. 1 that drugmakers including Pfizer, GlaxoSmithKline and Sanofi raised the list prices on more than 200 drugs. Later in the day, Bristol-Myers Squibb, Gilead Sciences and Biogen increased list prices of about 50 drugs.

The median price increase was about 5 percent, and nearly all of the price increases were below 10 percent.

Many branded drugmakers pledged to keep their U.S. list price hikes below 10 percent a year  following backlash from lawmakers and the public.

More articles on pharmacy:

Amazon's PillPack seeking to win over new insurers in 2020
Roche buys international rights to Sarepta's Duchenne drug for $750M
Former Aegerion sales rep defrauded insurers, stole identities to push cholesterol drug

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars